Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change Price Change
C 113.40 -0.59% -0.67
ABT closed down 0.59 percent on Tuesday, October 29, 2024, on approximately normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
10 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Stochastic Reached Oversold Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish -0.59%
Inside Day Range Contraction -0.59%
Gapped Up Strength -0.59%
Down 3 Days in a Row Weakness -0.59%
Fell Below 20 DMA Bearish -0.72%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low about 7 hours ago
Rose Above 50 DMA about 10 hours ago
50 DMA Resistance about 11 hours ago
Possible Inside Day 1 day ago
50 DMA Support 1 day ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Abbott Laboratories Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: S&P 500 Medicine Cancer Life Sciences Pain Infectious Diseases Diabetes Eye Pharmaceutical Products Inflammation Hypertension Glucose Influenza Hematology Lab Testing Diagnostic Products Lipid Vascular Disease Thyroid Health Care Products Nutritional Products Cataracts Fertility Blood Glucose Monitoring Immunoassay Contact Lens Fever Irritable Bowel Syndrome Influenza Vaccine Cataract Surgery Dyslipidemia Generic Pharmaceutical Vascular Products Generic Pharmaceuticals Data Management Software Lasik Lens Care Products Cholestasis Hypothyroidism Intrahepatic Cholestasis

Is ABT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 119.85
52 Week Low 90.6216
Average Volume 4,164,967
200-Day Moving Average 109.52
50-Day Moving Average 114.21
20-Day Moving Average 115.31
10-Day Moving Average 116.35
Average True Range 1.83
RSI (14) 43.82
ADX 24.86
+DI 19.58
-DI 20.72
Chandelier Exit (Long, 3 ATRs) 114.37
Chandelier Exit (Short, 3 ATRs) 116.63
Upper Bollinger Bands 119.36
Lower Bollinger Band 111.25
Percent B (%b) 0.27
BandWidth 7.03
MACD Line 0.40
MACD Signal Line 0.84
MACD Histogram -0.4347
Fundamentals Value
Market Cap 196.87 Billion
Num Shares 1.74 Billion
EPS 3.26
Price-to-Earnings (P/E) Ratio 34.79
Price-to-Sales 4.87
Price-to-Book 5.18
PEG Ratio 26.92
Dividend 2.08
Dividend Yield 1.83%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 115.49
Resistance 3 (R3) 115.70 115.22 115.14
Resistance 2 (R2) 115.22 114.69 115.11 115.02
Resistance 1 (R1) 114.31 114.36 114.07 114.10 114.91
Pivot Point 113.83 113.83 113.71 113.72 113.83
Support 1 (S1) 112.92 113.30 112.68 112.71 111.89
Support 2 (S2) 112.44 112.97 112.33 111.78
Support 3 (S3) 111.53 112.44 111.66
Support 4 (S4) 111.32